MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Making FDA a Friend, Not a Foe

Article-Making FDA a Friend, Not a Foe

Image courtesy of Araki Illustrations / Alamy Stock Photo IMG_2022-11-22-144114.jpg
During BIOMEDEVice Silicon Valley, a panel will discuss the various types of engagement that sponsors can have with FDA.

Engaging FDA can be a bit intimidating for some device makers. But it doesn’t have to be that way.  During BIOMEDevice Silicon Valley a panel will discuss the various types of engagement that sponsors can have with FDA, along with do's and don'ts for various types of interactions and the best times to engage.

It will cover the sponsor side and FDA side of the relationship.

Panelists Include:

  • Isabella Schmitt, Director of Regulatory Affairs at Proxima Clinical Research & Principal at M1MedTech
  • Pharoah Schnieber, COO at Boomerang Medical
  • Scott Trevino, Senior Vice President of Cybersecurity at Trimedx

 

 

 

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish